FLUID INFUSION SYSTEM THAT AUTOMATICALLY DETERMINES AND DELIVERS A CORRECTION BOLUS

Patent №

US 11,660,394

Granted

2023-05-30

Filed 2020

Owner

MEDTRONIC MINIMED, INC.

Lab

AI components

1

planning

Assignment

Recorded

Dataset

AIPD

2023_r1 edition

Application

17122445

A method of controlling an insulin infusion device involves controlling the device to operate in an automatic basal insulin delivery mode, obtaining a blood glucose measurement for the user, and initiating a correction bolus procedure when: the measurement exceeds a correction bolus threshold value; and a maximum basal insulin infusion rate is reached during the automatic basal insulin delivery mode. The correction bolus procedure calculates an initial correction bolus amount, and scales the initial amount to obtain a final correction bolus amount, such that a predicted future blood glucose level resulting from simulated delivery of the final correction bolus amount exceeds a low blood glucose threshold level. The final amount is delivered to the user during operation in the automatic basal insulin delivery mode.

PlanningA61M 5/14244A61M 5/1723A61B 5/14532A61B 5/4839A61B 5/4866A61B 5/7275G16H 20/17G16H 40/63+5 more

AI classification

Planning0.87
Knowledge representation0.11
Evolutionary computation0.09
AI hardware0.05
Natural language0.02
Vision0.00
Machine learning0.00
Speech0.00

Ownership

MEDTRONIC MINIMED, INC.

assignment · 546530203

Assignors

LINTEREUR, LOUIS J., ROY, ANIRBAN, GROSMAN, BENYAMIN, WEYDT, PATRICK E., PARIKH, NEHA J., WU, DI, DIANATY, ALI

On an employer assignment, the assignors are typically the inventors.

From the same owner

© 2026 NYSGPT2525 LLC